Excessive perioperative bleeding: Are fibrin monomers and factor xiii the missing link?

Anesthesiology

Volumn 110, Issue 2, 2009, Pages 212-213

  Spahn, Donat R ^a   Asmis, Lars M ^a,b  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; BLOOD CLOTTING FACTOR 13; FIBRIN; FIBRINOGEN; MONOMER; THROMBIN;

ALLOTRANSPLANTATION; BLEEDING; BLOOD CLOTTING; BLOOD TRANSFUSION; BRAIN SURGERY; CORONARY ARTERY BYPASS GRAFT; CROSS LINKING; EDITORIAL; HUMAN; INTRAOPERATIVE PERIOD; LABORATORY TEST; MEDICAL ERROR; MEDICAL INFORMATION; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION; RISK ASSESSMENT; SINGLE DRUG DOSE; THROMBOELASTOGRAPHY; TREATMENT PLANNING; NEOPLASM; NOTE; PEROPERATIVE COMPLICATION; PHYSIOLOGY;

BLOOD COAGULATION; FACTOR XIII; FIBRIN; HEMORRHAGE; HUMANS; INTRAOPERATIVE COMPLICATIONS; NEOPLASMS; PERIOPERATIVE CARE; THROMBIN;

EID: 61549131244     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0b013e3181942c65     Document Type: Editorial

References (12)

1. Koscielny J, Ziemer S, Radtke H, Schmutzler M, Pruss A, Sinha P, Salama A, Kiesewetter H, Latza R: A practical concept for preoperative identification of patients with impaired primary hemostasis. Clin Appl Thromb Hemost 2004; 10:195-204
2. Koscielny J, von Tempelhoff GF, Ziemer S, Radtke H, Schmutzler M, Sinha P, Salama A, Kiesewetter H, Latza R: A practical concept for preoperative management of patients with impaired primary hemostasis. Clin Appl Thromb Hemost 2004; 10:155-66
3. Korte WC, Szadkowski C, Gähler A, Gabi K, Kownacki E, Eder M, Degiacomi P, Zoller N, Devay J, Lange J, Schnider T: Factor XIII substitution in surgical cancer patients at high risk for intraoperative bleeding. Anesthesiology 2009; 110:239-45
4. Wettstein P, Haeberli A, Stutz M, Rohner M, Corbetta C, Gabi K, Schnider T, Korte W: Decreased factor XIII availability for thrombin and early loss of clot firmness in patients with unexplained intraoperative bleeding. Anesth Analg 2004; 99:1564-9
5. Korte W, Gabi K, Rohner M, Gahler A, Szadkowski C, Schnider TW, Lange J, Riesen W: Preoperative fibrin monomer measurement allows risk stratification for high intraoperative blood loss in elective surgery. Thromb Haemost 2005; 94:211-5
6. Korte W: [Fibrin monomer and factor XIII: A new concept for unexplained intraoperative coagulopathy]. Hamostaseologie 2006; 26:S30-5
7. Gerlach R, Tolle F, Raabe A, Zimmermann M, Siegemund A, Seifert V: Increased risk for postoperative hemorrhage after intracranial surgery in patients with decreased factor XIII activity: Implications of a prospective study. Stroke 2002; 33:1618-23
8. Shainoff JR, Estafanous FG, Yared JP, DiBello PM, Kottke-Marchant K, Loop FD: Low factor XIIIA levels are associated with increased blood loss after coronary artery bypass grafting. J Thorac Cardiovasc Surg 1994; 108:437-45
9. Godje O, Gallmeier U, Schelian M, Grunewald M, Mair H: Coagulation factor XIII reduces postoperative bleeding after coronary surgery with extracorporeal circulation. Thorac Cardiovasc Surg 2006; 54:26-33
10. Pocock SJ: When to stop a clinical trial. BMJ 1992; 305:235-40
11. Schroeder V, Chatterjee T, Kohler HP: Influence of blood coagulation factor XIII and FXIII Val34Leu on plasma clot formation measured by thrombelastography. Thromb Res 2001; 104:467-74
12. Furie B, Furie BC: Molecular basis of blood coagulation, Hematology: Basic Principles and Practice, 4th edition. Edited by Hoffman R. Philadelphia, Elsevier, 2005, pp 1946